The Value of 11C-Methionine PET in the Differential Diagnosis Between Brain Tumor Recurrence and Radionecrosis

2014 ◽  
pp. 895-910
Author(s):  
Andor W. J. M. Glaudemans ◽  
Roelien H. Enting ◽  
Mart A. A. M. Heesters ◽  
Ronald W. J. van Rheenen ◽  
Rudi A. J. O. Dierckx ◽  
...  
2014 ◽  
Vol 37 (6) ◽  
pp. E3 ◽  
Author(s):  
Stephanie Lescher ◽  
Sonja Schniewindt ◽  
Alina Jurcoane ◽  
Christian Senft ◽  
Elke Hattingen

Object Early postoperative MRI within 72 hours after brain tumor surgery is commonly used to assess residual contrast-enhancing tumor. The 72-hour window is commonly accepted because previous 1.5-T MRI studies have not found confounding postoperative reactive contrast enhancement in this time frame. The sensitivity to detect contrast enhancement increases with the field strengths. Therefore, the authors aimed to assess whether the 72-hour window is also appropriate for the MRI scanner with a field strength of 3 T. Methods The authors retrospectively analyzed findings on early postsurgical MR images acquired in 46 patients treated for high-grade gliomas. They performed 3-T MRI within 7 days before surgery and within 72 hours thereafter. The appearance of enhancement was categorized as postoperative reactive enhancement or tumoral enhancement by comparison with the pattern and location of presurgical enhancing tumor. Results Postoperative reactive enhancement was present in 15 patients (32.6%). This enhancement, not seen on presurgical MRI, had a marginal or leptomeningeal/dural pattern. In 13 patients (28.3%) postsurgical enhancement was found within the first 72 postoperative hours, with the earliest seen 22:57 hours after surgery. Subsequent MR scans in patients with postoperative reactive enhancement did not reveal tumor recurrence in these regions. Conclusions Postoperative reactive enhancement earlier than 72 hours after brain tumor surgery can be expected in about one-third of the cases in which a 3-T scanner is used. This might be due to the higher enhancement-to-brain contrast at higher field strengths. Therefore, the time window of 72 hours does not prevent reactive enhancement, which, however, can be recognized as such comparing it with presurgical enhancing tumor.


1976 ◽  
Vol 62 (4) ◽  
pp. 407-414 ◽  
Author(s):  
Yehuda Shoenfeld ◽  
Albert I. Pick ◽  
Sarah Schreibman ◽  
Helena Kessler ◽  
Moshe Dintzman

A 3 year old child with primary hepatocellular carcinoma and high AFP concentrations is described. Following hemihepatectomy, a sharp decrease and return to normal of serum AFP concentrations indicated the completeness of the surgical procedure. Repeat-normal serum AFP concentrations (less than 19 ng/ml), found during a three year follow-up, correlated well with the absence of clinical, laboratory and x-ray evidence of tumor recurrence. The differential diagnosis of abnormal AFP concentrations in childhood is discussed, and the importance of the AFP assay in the follow-up of post-hemihepatectomy patients for the assessment of the completeness of the surgical procedure, the prognosis, and the early detection of tumor recurrence is stressed.


Author(s):  
Tilman R. Rohrer ◽  
Thorsten Langer ◽  
Gerhard G. Grabenbauer ◽  
Michael Buchfelder ◽  
Matthias Glowatzki ◽  
...  

2006 ◽  
Vol 33 (6Part16) ◽  
pp. 2182-2182 ◽  
Author(s):  
A Krishnan ◽  
I Asher ◽  
D Davis ◽  
D Fuller ◽  
P Okunieff ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (7) ◽  
pp. e0132515 ◽  
Author(s):  
Ryogo Minamimoto ◽  
Toshiyuki Saginoya ◽  
Chisato Kondo ◽  
Noriaki Tomura ◽  
Kimiteru Ito ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document